Hints and tips:
Related Special Reports
...Two other Icahn nominees failed to attract enough votes to win board seats, paving the way for Illumina chief executive Francis deSouza and director Robert Epstein to be re-elected....
...Monsanto, which exposed Bayer to billions of dollars in litigation costs tied to the weedkiller glyphosate....
...“There was a time in that transition where the market wasn’t necessarily following where they were in their turnaround,” she said. “We’re in that moment right now.”...
...The move to raise $500m in art-backed securities comes at a moment of deep distrust of Drahi in the bond market, however....
...It’s a funny phrase because it makes perfect sense in the pharmaceutical context — they’re contractors who manufacture drugs and help with some of the development process — but also sounds a bit like they...
...One example comes from a comparison of the disclosures by WuXi Biologics, a pharmaceutical company that listed in 2017, and WuXi XDC, a unit it spun off and listed last year....
...In its first challenge to a pharmaceutical deal in more than a decade, Khan’s Federal Trade Commission had sought to block the deal, arguing greater market power would lead to higher prices for patients....
...Janssen is the pharmaceutical division of J&J....
...However, two other Icahn nominees failed to attract enough votes to win board seats, paving the way for Illumina chief executive Francis deSouza and director Robert Epstein to be re-elected....
...Last week the EU appeared relatively cavalier about protecting pharmaceutical IP in its own market....
...Tellurian said in a securities filing this year that it had not been aware of any such arrangement, which “may have created a conflict of interest”....
...Brent Wisner, the co-lead liaison counsel for claimants in the Zantac California state litigation, said he was focused on pursuing the litigation in the state courts....
...As a young man in the early 1980s, he ran twice, unsuccessfully, for Congress in Connecticut. In 1983, he founded Aristotle Inc, a technology consultancy that sold voter data to political campaigns....
...It has also acquired several biotech companies with drug candidates in late-stage development, including Biohaven Pharmaceuticals and Arena Pharmaceuticals....
...But his career stalled in 2010, and after a period in the wilderness he embarked on a quixotic mission to re-emerge as a leading light in the Chinese semiconductor industry....
...Instead of paying cash to acquire VMware outright, Dell issued EMC shareholders the tracking stock that would become the disputed security in the litigation....
...first successful litigation of its kind against the Japanese tax authority at the Supreme Court....
...Since the US pharmaceutical industry is stronger in this field, there was even more gloom about Washington allowing broad IP waivers here. And thus it has proved....
...So, for example, the fact that we, as a country, might not regulate who gets to sit in these auction markets and collect data, just for bidding purposes, is astounding to me from a national security perspective...
...In his 22 years as general counsel, Gustavsson has broadened the legal function’s remit to include enterprise risk management, security, and corporate development....
...The model is being copied in a deal with Barbados that re-engineers part of its sovereign debt to support ocean protection....
...Insider cont.: In his view, unregulated exchanges aren’t safe, regardless of their size, so he’s turned to crypto exchange WonderFi, which is regulated by the Ontario Securities Exchange....
...Businesses were liable “for every statement made within a bond prospectus or sustainable financing framework, and these could become the subject of securities litigation”, Fitch said....
...If you’re really going to make trade and strategic policy cohere, national security needs to be invoked transparently and judiciously, not to excuse blatant protectionism....
...The company declined to comment on its proposed relisting plans, but one senior executive said it was now “in a position where we’re more comfortable re-engaging with public investors” and that it wanted...
International Edition